Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.
暂无分享,去创建一个
Loyd | Ary | G. Greenberg | ichard | onald | B. Feagan | tephen | G. Wild | R. Fedorak | E. Irvine | L. Sutherland | G R Greenberg | E J Irvine | A. Steinhart | B G Feagan | J Rochon | R N Fedorak | G Wild | L Sutherland | A H Steinhart | R Gillies | M Hopkins | an | J. Rochon | M. Hopkins | J. E. | Ordon | Ames | H. B | Anauer | H. A | Reenberg | Ohn | Rvine | Opkins | R. Gillies | G. R | H. B. | Ochon | F. N. | Edorak | Ild | Utherland | H. A. | Illary | Teinhart | Illies | Arybeth | M. W.D. | G. R. | F. N. | Ohn | Ames | Ochon | Ichard | Edorak | J. E | An | Ary | Ild | Utherland | H. A. | Illary | Teinhart | G. R. | Illies | Arybeth | M. W.D.
[1] G. Searles,et al. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature. , 1987, The Journal of rheumatology.
[2] F Kern,et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.
[3] J. Adachi,et al. Corticosteroid-induced osteoporosis. , 1993, Seminars in arthritis and rheumatism.
[4] P. McCullagh,et al. Generalized Linear Models, 2nd Edn. , 1990 .
[5] J. Kremer,et al. Methotrexate for rheumatoid arthritis : suggested guidelines for monitoring liver toxicity , 1994 .
[6] A. Eisen,et al. METHOTREXATE THERAPY IN PSORIATIC ARTHRITIS; DOUBLE-BLIND STUDY ON 21 PATIENTS. , 1964, JAMA.
[7] Q. Whiting-O'Keefe,et al. Methotrexate and histologic hepatic abnormalities: a meta-analysis. , 1991, The American journal of medicine.
[8] S. Meltzer,et al. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. , 1989, Annals of internal medicine.
[9] A. Mackenzie,et al. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. , 1990, The American journal of medicine.
[10] D. Sachar. Budesonide for inflammatory bowel disease. Is it a magic bullet? , 1994, The New England journal of medicine.
[11] G. Greenberg,et al. Oral Budesonide for Active Crohn's Disease , 1994 .
[12] S N Rasmussen,et al. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. , 1989, The New England journal of medicine.
[13] G. Guyatt,et al. A new measure of health status for clinical trials in inflammatory bowel disease. , 1989, Gastroenterology.
[14] K. Ewe,et al. European cooperative Crohn's disease study (ECCDS) : Results of drug treatment , 1984 .
[15] E. Schiff,et al. Methotrexate-induced chronic liver injury: guidelines for detection and prevention. The ACG Committee on FDA-related matters. American College of Gastroenterology. , 1988, The American journal of gastroenterology.
[16] P. Dale,et al. Pancytopenia associated with low dose methotrexate therapy. A regional survey. , 1993, The Journal of rheumatology.
[17] R. Kozarek,et al. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. , 1989, Annals of internal medicine.
[18] R. Sturdevant,et al. Azathioprine-related pancreatitis in patients with Crohn's disease. , 1979, Gastroenterology.
[19] S. Hanauer,et al. Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group. , 1993, Gastroenterology.
[20] J. H. Klippel,et al. Methotrexate in rheumatoid arthritis. , 1985, The New England journal of medicine.
[21] D. Furst,et al. The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis. , 1991, Seminars in arthritis and rheumatism.
[22] J. Rochon,et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. , 1994, Gastroenterology.
[23] P. McCullagh,et al. Generalized Linear Models , 1992 .
[24] L. Moreland,et al. Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients. , 1989, Seminars in arthritis and rheumatism.
[25] R. Jennrich,et al. Unbalanced repeated-measures models with structured covariance matrices. , 1986, Biometrics.
[26] A. Laupacis,et al. Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial Investigators. , 1994, The New England journal of medicine.
[27] D. Jewell,et al. Oral cyclosporin for chronic active Crohn's disease: a multicentre controlled trial , 1994 .
[28] M. Guttadauria,et al. Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. , 1984, Arthritis and rheumatism.
[29] M. Weinblatt,et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. , 1985, The New England journal of medicine.
[30] S. Kreiner,et al. Alimentary tract andpancreas Prognosis inCrohn's disease -based onresults froma regional patient group fromthecounty ofCopenhagen , 1985 .
[31] J. Adachi. Corticosteroid-induced osteoporosis. , 1996, Drug and therapeutics bulletin.